ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast to Dierks et al. who indicated that Hh pathway activation in BCR-ABL+ leukaemogenesis was via upregulation of SMO27, we found no evidence for this; with no increased expression of SMO at the gene or protein level in CP-CML.